It is a chemicals and materials private limited company based in Gurgaon, Haryana, India, established in 2015.
2015 | Gurgaon, Haryana, India | ActiveHyades Pharmaceuticals Private Limited, a active private limited company, was established on 15 June 2015 in Gurgaon, Haryana, India. Engaging in chemical distribution & retail within the trade sector, it holds CIN: U74140HR2015PTC055774. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Babita Sinha (Director), Subodh Kumar Sinha (Director). Past directors included Aditi Sinha, Saket Kumar Singh, Babita Sinha. Its latest AGM occurred on 28 December 2022, with the balance sheet filed on 31 March 2022. It is based at Unit No- 504 A, Unitech Arcadia South City 2, Gurgaon, Haryana, 122001.
U74140HR2015PTC055774
055774
15 June 2015
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Hyades Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Babita Sinha | Director | 01 May 2018 | Current |
| Subodh Kumar Sinha | Director | 15 Jun 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Jun 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 30 Jun 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Jun 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hyades Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 6.51% decrease. The company also saw a slight improvement in profitability, with a 7.87% increase in profit. The company's net worth moved up by a moderate rise of 8.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Hyades Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Hyades Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hyades Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyades Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Hyades Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Dec 2022 as per latest MCA records. was recorded as a recent event.
The activity Hyades Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi. was completed.
Babita Sinha was appointed as a Director was appointed as a Director on 01 May 2018 & has been associated with this company since 7 years 7 months . was recorded as a recent event.
Progress on Subodh Kumar Sinha was appointed as a Director was appointed as a Director on 15 Jun 2015 & has been associated with this company since 10 years 6 months . was documented.
Progress on Hyades Pharmaceuticals Private Limited was registered on 15 Jun 2015 with Roc Delhi & aged 10 years 6 months as per MCA records. was documented.
The CIN of Hyades Pharmaceuticals Private Limited is U74140HR2015PTC055774.
Hyades Pharmaceuticals Private Limited is headquartered at Unit No- 504 A, Unitech Arcadia South City 2, Gurgaon, Haryana, 122001.
Hyades Pharmaceuticals Private Limited was incorporated on 15 June 2015.
The current directors of Hyades Pharmaceuticals Private Limited are
The primary industry of Hyades Pharmaceuticals Private Limited is Trade.
Hyades Pharmaceuticals Private Limited is unlisted.
The authorized capital of Hyades Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Hyades Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX